Pharma

Dr. Yuri Maricich, chief medical officer at Pear Therapeutics, speaks on his company's experience bringing a digital therapeutic product through the regulator's experimental program for health software.

Somryst, a prescription digital therapeutic combining cognitive behavioral therapy and personalized sleep restriction, is the first software product to put the FDA's early Precertification Program framework through its paces. 

Chairman of the UAE’s IBC Group is working with the UK biotech research company, Vaxbio to launch an affordable vaccine that the company hopes to launch by the summer.

The platform will include an AI-enabled patient-engagement tool and smart pricing. 

The large, multi-site investigation described clear improvement in objective symptoms of pediatric attention deficit, but was a bit muddier when describing subjective measures and long-term efficacy.

A recently published analysis of eight digital studies found a median dropoff of 5.5 days, as well as a predominantly young and white pool of participants.

The high street beauty and health retailer is taking one step further to introduce digital services for its customers.